FourThought Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
FourThought Financial Partners's BMY Position: Q2 2026 in Review
FourThought Financial Partners reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q2 2026, selling an estimated $29.6K and leaving 6,683 shares worth $385K. The position accounts for 0.03% of the portfolio, ranked #233.
FourThought Financial Partners first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.5M in Q3 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- FourThought Financial Partners held 6,683 shares of Bristol-Myers Squibb worth $385K as of Q2 2026.
- FourThought Financial Partners sold 516 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.6K.
- Bristol-Myers Squibb made up 0.03% of FourThought Financial Partners's portfolio in Q2 2026, its #233 holding.
- FourThought Financial Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- FourThought Financial Partners's Bristol-Myers Squibb position peaked at $6.5M in Q3 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.